Navigation Links
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
Date:11/7/2013

SAN FRANCISCO, Nov. 7, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2013.

Cash and investments in marketable securities at September 30, 2013 were $208.6 million as compared to $302.2 million at December 31, 2012.

"Nektar continues to have a very productive year achieving significant milestones with both our partnered programs and proprietary pipeline," said Howard W. Robin, President and Chief Executive Officer of Nektar. "For naloxegol, the MAA in Europe and NDS in Canada are now accepted for filing and the NDA in the U.S. was submitted for filing in mid-September.  Naloxegol could be the first once-daily oral peripheral opioid antagonist approved to treat opioid-induced constipation.  BAX 855, Baxter's longer-acting PEGylated Factor VIII therapy, which is in Phase 3, remains on track for a 2014 BLA filing.  Finally, while I am disappointed that the results from the Phase 2 efficacy study for NKTR-181 were confounded by an unusual placebo response, we are working with our advisors and the FDA to design an optimal Phase 3 program, which should start by the middle of 2014." 

Revenue in the third quarter of 2013 was $60.9 million as compared to $18.4 million in the third quarter of 2012. Year-to-date revenue for 2013 was $117.8 million as compared to $60.0 million in the first nine months of 2012.  Revenues included non-cash royalty revenue, related to our 2012 royalty monetization, of $4.5 million and $12.7 million in the third quarter and year-to-date for 2013, respectively, and $3.4 million in the third quarter and $6.9 million in the first nine months of 2012. This non-cash royalty revenue is offset by non-cash interest expense. The increases in revenue in the third quarter and first nine months of 2013 as compared to the same periods in
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
8. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
10. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
11. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... DUBLIN , July 30, 2014 ... the "Global and Chinese Aseptic Packaging Industry Report ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and ... in-depth study on the current state of the global ... situation. The report provides a basic overview of ...
(Date:7/30/2014)... --  Unique Pizza and Subs Corporation ("Unique," ... Delaware Corporation, is pleased to announce it has ... ("Larasan"), a nature-based pharmaceutical company that produces and distributes ... will work with Unique to help distribute its ... distribution network throughout China ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... , , BIRMINGHAM, Ala., Nov. 19 ... the pricing of a public offering of 5,000,000 shares of ... proceeds of $48.75 million. All of the shares are ... statement previously filed with the Securities and Exchange Commission. ...
... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ ... ingredients (APIs), announced that its,Tainan facility has received ... The Certification confirms ScinoPharm,s,competency and proficiency in the ... applies to specific laboratories and,production areas used for ...
Cached Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2
(Date:7/31/2014)... people are unaware of getting old. However, the truth is ... we were born on earth. Human beings will experience a ... people may live without children in their old age. In ... to worry about that. A lot of reliable enterprises are ... manufacturer , is one of them. The company is not ...
(Date:7/31/2014)... Care Communications, Inc., (CARE) a national health ... the Elite Award for “Recruitment, Selection and Orientation” from ... elite awards presented as part of “Chicago’s ... 2014 awards competition. This marks the seventh consecutive year ... competition. CARE has also been chosen as a national ...
(Date:7/31/2014)... Recently, iFitDress.com, a professional company of women’s ... by announcing a new collection of high low ... at very low prices. In addition, worldwide clients can ... officials want to save both time and money for ... shopping experience to all online visitors. On its website, ...
(Date:7/31/2014)... National non-profit World T.E.A.M. Sports’ annual ... Range September 12-14, following two years in the high ... of disabled and able-bodied athletes competing together in an ... challenging by experienced adventure athletes. , Hosted at the ... the Colorado River in the rugged Gore Mountains northwest ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 USHIO ... the specialty and general lighting marketplaces, today announced ... kits. These will allow users to transform existing, ... fixtures within minutes. , USHIO America’s Uphoria LED ... 6-inch downlight cans, allowing the user to upgrade ...
Breaking Medicine News(10 mins):Health News:FodayAuto.com: Do Not Be Afraid of Getting Old 2Health News:Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers 2Health News:Discounted High Low Wedding Dresses Available At iFitDress.com 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 3Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2
... well known, but a new study has found that it's ... they're given a rewarding task that tests their powers of ... and student colleague Michelle Corman studied men who were each ... raise their blood alcohol level to 0.1, slightly over the ...
... found a gene variant that raises a childs risk ... condition attributed to inflammation of the gastrointestinal tract . ... of a German study that identified the same gene ... disease is a chronic and painful condition attributed to ...
... Scientists have identified the first gene that is linked ... sleep disorder that affects millions of people worldwide . ... overpowering need to move the legs and is also ... ,,We now have concrete evidence that RLS is an ...
... for a swim only to be struck by flesh-eating ... in danger of losing a life, possibly even his ... a tissue-destroying disease caused by a bacterium called Vibrio ... suffering from multiple organ failure because the disease has ...
... revealed that the star had a miscarriage in 2005 . ... ever since they tied the knot in September 2005, and now ... star did in fact become pregnant, but she lost the baby. ... kids of her own. Demi and Ashton have been trying (to ...
... release of more than a thousand prisoners has failed ... and prisoner rehabilitation programmes, said the BMA today. ... anniversary of the Ministry of Justices introduction of emergency ... and Welsh prisons. A key element of the Government ...
Cached Medicine News:Health News:Alcohol may Help You to Be Cool 2Health News:Gene Variants for Crohn's Disease Identified 2Health News:Gene Variants for Crohn's Disease Identified 3Health News:Gene Linked With Restless Leg Syndrome Spotted Out 2Health News:Texan Battles Flesh-eating Bacteria Contracted While Swimming 2Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2
... QuickThaw Plasma Thawing Systems from Helmer use both ... times while ensuring the safety of your plasma. ... models have dual baskets with independent controls that ... ,The QuickThaw is also convenient to operate, allowing ...
... systems are automated, easy to operate and ... outside environment by flexible snap-seal pockets which ... viral contamination of the water. Offered in ... can also accommodate bags of various sizes. ...
... Thawing Systems from Helmer use both controlled temperature ... ensuring the safety of your plasma. The DH4 ... dual baskets with independent controls that will accommodate ... is also convenient to operate, allowing you to ...
Inquire...
Medicine Products: